Insider · CIK 0001751824

Tommasi Ruben

Reports to the SEC for 1 company · WALTHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001751824

Forms 4 and 5

Insider transactions

26 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-07-11	Entasis Therapeutics Holdings Inc.D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−150K sh	—	—	0
2022-07-11	Entasis Therapeutics Holdings Inc.Stock Option (right to buy)J Other	Chief Scientific Officer	JOther	−98.7K sh	—	—	0
2022-07-11	Entasis Therapeutics Holdings Inc.Stock Option (right to buy)J Other	Chief Scientific Officer	JOther	−50K sh	—	—	0
2022-07-11	Entasis Therapeutics Holdings Inc.Stock Option (right to buy)J Other	Chief Scientific Officer	JOther	−24.9K sh	—	—	0
2022-07-11	Entasis Therapeutics Holdings Inc.Stock Option (right to buy)J Other	Chief Scientific Officer	JOther	−6,465 sh	—	—	0
2022-07-07	Entasis Therapeutics Holdings Inc.U Disposition from Tender	Chief Scientific Officer	UDisposition from Tender	−39.6K sh	$2.20	−$87.1K	0
2022-01-18	Entasis Therapeutics Holdings Inc.A Award	Chief Scientific Officer	AAward	+125K sh	—	—	189,596
2021-11-02	Entasis Therapeutics Holdings Inc.F Tax Payment	Chief Scientific Officer	FTax Payment	−3,669 sh	$2.94	−$10.8K	64,596
2021-10-19	Entasis Therapeutics Holdings Inc.A Award	Chief Scientific Officer	AAward	+25K sh	—	—	72,024
2021-10-19	Entasis Therapeutics Holdings Inc.S Sale	Chief Scientific Officer	SSale	−3,759 sh	$3.19	−$12K	68,265
2021-07-16	Entasis Therapeutics Holdings Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−22.8K sh	—	—	0
2021-07-16	Entasis Therapeutics Holdings Inc.Employee Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+15.2K sh	—	—	15,210
2021-07-16	Entasis Therapeutics Holdings Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−15.6K sh	—	—	0
2021-07-16	Entasis Therapeutics Holdings Inc.Employee Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+12K sh	—	—	12,024
2021-07-16	Entasis Therapeutics Holdings Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−50.4K sh	—	—	0
2021-07-16	Entasis Therapeutics Holdings Inc.Employee Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+28K sh	—	—	28,006
2021-07-16	Entasis Therapeutics Holdings Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−56.5K sh	—	—	0
2021-07-16	Entasis Therapeutics Holdings Inc.Employee Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+43.5K sh	—	—	43,460
2021-01-15	Entasis Therapeutics Holdings Inc.A Award	Chief Scientific Officer	AAward	+25K sh	—	—	47,024
2020-01-23	Entasis Therapeutics Holdings Inc.Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+50K sh	—	—	50,000
2019-01-18	Entasis Therapeutics Holdings Inc.Employee Stock Option (right to buy)A Award	Chief Scientific Officer	AAward	+56.5K sh	—	—	56,500
2018-12-21	Entasis Therapeutics Holdings Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+11.8K sh	$3.74	+$44.1K	11,788
2018-12-21	Entasis Therapeutics Holdings Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+10.2K sh	$3.11	+$31.8K	22,024
2018-12-21	Entasis Therapeutics Holdings Inc.Employee Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−11.8K sh	—	—	6,465
2018-12-21	Entasis Therapeutics Holdings Inc.Employee Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−10.2K sh	—	—	24,858
2018-09-25	Entasis Therapeutics Holdings Inc.Employee Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+50.4K sh	—	—	50,411

Recent filings

Accepted (ET)
Jul 114
Tommasi Ruben0001104659-22-078802
SEC(opens sec.gov)
Feb 154
Tommasi Ruben0001104659-22-023787
SEC(opens sec.gov)
Jan 194
Tommasi Ruben0001104659-22-005430
SEC(opens sec.gov)
Nov 34
Tommasi Ruben0001104659-21-133623
SEC(opens sec.gov)
Oct 204
Tommasi Ruben0001104659-21-128059
SEC(opens sec.gov)
Jan 194
Tommasi Ruben0001104659-21-005321
SEC(opens sec.gov)
Jan 274
Tommasi Ruben0001104659-20-007115
SEC(opens sec.gov)

Companies

Entasis Therapeutics Holdings Inc.Chief Scientific Officer

Address

C/O ENTASIS THERAPEUTICS HOLDINGS INC. 35 GATEHOUSE DRIVE

WALTHAM, MA, 02451